• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Godavari Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4985.0
  • ISIN : INE362C01012
92.22 2 (2.31%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    88.01

  • Today’s High

    95.94

  • Open

    90.17

  • Perv Close

    90.14

  • 52W Low

    79.00

  • 52W High

    155.00

Key Indicators

  • P/E(TTM)

    11.23

  • Mar.Cap (₹Cr.)

    69.44

  • Div & Yield %

    0.00

  • Book Value(₹)

    55.36

  • Debt-Equity Ratio

    2.31

  • AGM Date

    30-Apr-2025

  • EPS

    8.21

  • P/E Ratio

    11.23

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    69.44

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.53

  • BV (₹)

    55.40

  • Sales( ₹ in Cr.)

    156.71

  • NP (in Cr.)

    5.62

  • NP Var(%)

    56.0

  • Div%

    0.0

  • CPS (₹)

    10.10

  • EPS (₹)

    7.50

  • Traded Value (₹ in Lakhs)

    69.44

  • 52 Week High

    155.00

  • 52 Week Low

    79.00

  • Price BSE

    92.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    69.44

  • P/C Ratio

    9.10

  • P/E Ratio

    12.30

  • Price Vs.BV

    7.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 156.71 159.62 161.11 122.67 95.70 83.54
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 156.71 159.62 161.11 122.67 95.70 83.54
Other Income 0.62 0.88 0.28 0.41 0.33 0.24
Stock Adjustments 1.14 9.76 -2.48 -2.44 0.71 2.04
Total Income 158.47 170.26 158.91 120.64 96.74 85.82
EXPENDITURE :            
Raw Materials 121.95 137.82 127.97 94.15 77.38 66.95
Power and Fuel Cost 8.51 6.66 5.46 4.76 4.84 4.20
Employee Cost 5.13 4.84 4.96 3.94 3.45 3.45
Other Manufacturing Expenses 3.07 3.27 4.14 3.15 1.01 1.49
Selling and Administration Expenses 1.50 1.27 1.38 1.24 1.29 0.91
Miscellaneous Expenses 4.47 5.60 3.42 3.16 2.41 3.10
Employee Benefit Expenses 5.13 4.84 4.96 3.94 3.45 3.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 144.64 159.47 147.33 110.39 90.37 80.11
Operating Profit 13.84 10.81 11.57 10.25 6.36 5.72
Interest 4.92 3.93 2.85 3.32 2.91 2.89
Gross Profit 8.92 6.88 8.72 6.93 3.45 2.83
Depreciation 1.99 1.94 1.70 1.22 1.16 1.09
Profit Before Tax 6.93 4.94 7.02 5.71 2.29 1.74
Current Tax 1.16 1.02 1.23 1.19 0.39 0.36
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.22 0.13 0.55 0.39 -0.10 0.18
Reported Net Profit 5.55 3.79 5.25 4.13 2.00 1.21
Extraordinary Items -0.07 0.18 0.00 0.00 0.00 0.00
Adjusted Net Profit 5.62 3.61 5.25 4.13 2.00 1.21
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 14.54 10.75 5.51 1.38 -0.62 -1.83
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 20.09 14.54 10.75 5.51 1.38 -0.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.37 5.03 6.97 5.48 2.66 1.60
Earnings Per Share(Adj)-Unit Curr 7.37 5.03 6.97 5.48 2.66 1.60
Book Value 51.74 44.38 39.35 32.38 26.90 24.24
Book Value(Adj)-Unit Curr 51.74 44.38 39.35 32.38 26.90 24.24

Shareholding Pattern

  • Promoter Group

    52.63%

  • Public Share Holding

    47.37%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,963,200 52.63 3,963,200 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,963,200 52.63 3,963,200 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 37,500 0.50 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 37,500 0.50 0 4
2] Non Institution
Bodies Corporate 188,625 2.50 143,625 32
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 321,421 4.27 105,521 132
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 13,056 0.17 13,056 24
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 988,759 13.13 986,659 20
Individuals holding nominal share capital up to Rs. 1 lakh 2,017,939 26.80 1,813,186 7,659
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,529,800 46.87 3,062,047 7,867
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,530,500 100.00 7,025,247 7,881

Company Background

Godavari Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Godavari Drugs Ltd
  • BSE Code : 4985.0
  • ISIN : INE362C01012

  • Incorporation Year

    1987

  • Registered Office

    Mayfair 1-8-303-34
    Sardar Patel Road, Secunderabad,
    Andhra Pradesh-500003

  • Telephone

    91-40-27849700/27844557

  • FAX

    91-40-27849859

  • Chairman

    Ghanshyam Jaju

  • Managing Director

    Mukund Kakani

  • Company Secretary

    Venkatesh Achanta

  • Auditor

    Ayyadevara & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Godavari Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Godavari Drugs 92.22 157.33 156.71 11.29 14.14
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92